Buying

Where to buy tirzepatide, and which options are legal

A prescription, a compounded vial, a research-labelled powder, a parcel from overseas. Only one of them is a legal way to buy an approved drug. Here is where each channel stands in 2026.

19 November 2026 5 min read By Peptide AI Editorial policy

You can buy tirzepatide legally in the US only on a prescription. It is an FDA-approved medicine, sold as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management, and a licensed pharmacy fills it like any other prescription drug.

That is the short answer to where to buy tirzepatide. The longer one is about the other places it shows up for sale: compounded vials from telehealth sites, and powder sold online as a research chemical. Those channels still exist, and they are not what they were in 2024. This page sets out each channel, what changed, and what to check before you order. It is general information, not legal or medical advice, and it does not name or rank any seller.

The short version

  • A prescription is the legal route. Any licensed prescriber can write one, in person or by telehealth. The pharmacy carries the testing and the traceability.
  • The broad compounding window has closed. FDA declared the tirzepatide shortage resolved on 19 December 2024. Copies made under that exception had to stop in 2025.
  • Research-labelled tirzepatide is not an approved drug. In a public lab-testing database, 67 of the last 195 samples with a result failed.
  • Overseas orders are not a workaround. FDA says importing unapproved drugs for personal use is illegal in most circumstances.

Where to get tirzepatide: the four channels

ChannelLegal statusWhat you getWhat to check
Prescription, filled by a licensed pharmacyLegal. Mounjaro and Zepbound are FDA-approved.An approved pen or vial, made under drug manufacturing rules and traceable by lot.Insurance coverage, or the self-pay price. The costs page has current figures.
Prescription for a compounded copyNarrow. Allowed when a prescriber documents a change that makes a significant difference for you, and in small numbers under FDA's April 2026 policy.A vial made by a compounding pharmacy. Not FDA-approved, and not a generic.The documented reason, and which pharmacy prepares it.
Research-use-only vialsNot an approved drug. Sold for laboratory use, not for people.Powder from a seller, with no drug manufacturing controls.An independent test of your own lot. About a third of recent samples failed.
Ordering from overseasImporting unapproved drugs for personal use is illegal in most circumstances.Whatever arrives, if customs does not refuse or detain it.There is no check that makes this channel legal.

Can you buy tirzepatide online?

Yes, on a prescription. A telehealth visit is a medical visit like any other: the clinician must be licensed in the state where you are when the visit happens, and the prescription goes to a pharmacy that fills it. That is a legal way to buy tirzepatide online.

The manufacturer also sells Zepbound single-dose vials direct to self-pay patients. A prescription is still required, and the price depends on the dose strength. The GLP-1 costs page keeps the dated figures, and how to find a GLP-1 provider lists the questions worth asking before you pick a prescriber. Ask one of them plainly: is this the FDA-approved product or a compounded preparation?

A site that sells tirzepatide without a prescription is not selling an approved drug through a legal channel, whatever the label says.

Peptide AI's prescription route through licensed telehealth is coming soon. It is not open yet, and when it opens it will lead with approved medicines like this one.

Is compounded tirzepatide legal?

Only in narrow cases now. Compounding pharmacies may not normally make copies of an approved drug that is on the market. A drug on FDA's shortage list is the exception, and tirzepatide was on that list from December 2022. FDA declared the shortage resolved on 19 December 2024. The grace period for 503A pharmacies ran into early 2025, and for 503B outsourcing facilities to 19 March 2025. Courts have so far declined to block FDA's decision.

What is left, under FDA's April 2026 clarification:

  • A documented clinical difference. A compounded vial is not treated as a copy when the prescriber determines and documents a change that makes a significant difference for that patient.
  • Small volumes at 503A pharmacies. FDA said it does not intend, for now, to act against a 503A pharmacy that fills four or fewer prescriptions of a copy in a calendar month.
  • Not at 503B facilities. Tirzepatide is not on the 503B bulks list and is not in shortage. A May 2026 proposal would keep it off that list. It is still a proposal.

FDA has also sent warning letters to telehealth companies over compounded GLP-1 marketing, and it says companies cannot call a compounded product a generic version of an approved drug. As of 31 May 2026, FDA had received more than 730 adverse event reports associated with compounded tirzepatide. A report shows that an event was reported, not that the product caused it. The full dated sequence is on our FDA and compounded GLP-1 page.

Tirzepatide for sale as a research peptide

Search "tirzepatide for sale" and much of what comes back is vials labelled for research use only. They carry the same molecule name. They are a different product. Products sold as research use only are not FDA-approved drugs.

The test data shows why that matters. Of the last 195 tirzepatide samples with a result in a public lab-testing database, 128 passed and 67 failed, a 66 percent pass rate. A pass covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch. Our tirzepatide test results page explains the standard behind those numbers.

Some vials sold as "GLP-2" or "GLP-3" are tirzepatide or retatrutide under a nickname. The slang page sorts out which is which.

Before you buy tirzepatide

A prescription filled by a licensed pharmacy is the safer route, because the pharmacy does the checking. Outside that route, three checks come first:

  • Vet the seller. A lot-specific report, a named independent lab, raw data, and a report that verifies on the lab's own site. How to vet a peptide supplier has the full list.
  • Test your own lot. A seller's report covers the sample the seller picked. How to get peptides tested covers sending a vial and what the result proves.
  • Know the legal picture. Is it legal to buy peptides? covers research labels, personal import and state rules.

None of these makes a research-labelled vial fit for people. They tell you what is in it.

Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.

Questions people ask

Where can I buy tirzepatide legally?

From a licensed pharmacy, on a prescription. Tirzepatide is FDA-approved as Mounjaro and Zepbound. Any licensed prescriber can write for it, including a telehealth clinician licensed in your state.

Can you buy tirzepatide without a prescription?

Not legally in the US. Tirzepatide sold without a prescription is not an approved drug sold through a legal channel, whatever the label says. Research-use-only vials are not FDA-approved drugs.

Is compounded tirzepatide still legal?

Only in narrow cases. FDA declared the tirzepatide shortage resolved on 19 December 2024, and the grace periods ended in 2025. A 503A pharmacy can still compound it when a prescriber documents a significant difference for the patient, and FDA said it does not intend, for now, to act against one that fills four or fewer copies a month.

Is research tirzepatide the same as Zepbound?

No. It carries the same molecule name, but Zepbound is an approved drug made under drug manufacturing rules. A research-labelled vial is not, and 67 of the last 195 tested samples failed.

Can I order tirzepatide from overseas?

FDA says importing unapproved drugs for personal use is illegal in most circumstances, and shipments can be refused or detained. An overseas vial is also outside every check a US pharmacy runs.

Sources

  1. Declaratory order: resolution of shortages of tirzepatide injection products (Mounjaro and Zepbound), U.S. Food and Drug Administration, 19 December 2024
  2. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, U.S. Food and Drug Administration, updated 1 April 2026
  3. List of bulk drug substances for which there is a clinical need under section 503B, Federal Register, 1 May 2026
  4. FDA's concerns with unapproved GLP-1 drugs used for weight loss, U.S. Food and Drug Administration, current as of 1 October 2026
  5. FDA intends to take action against non-FDA-approved GLP-1 drugs, U.S. Food and Drug Administration, 6 February 2026
Free on iOS and Android

Log it once. See it all on one timeline.

Doses, food, training, labs, sleep and scans on one timeline. On iOS and Android.

The PeptideAI protocol screen with a weekly GLP-1 dose on it.